Showing 1 - 9 results of 9 for search 'Peera Jaru-ampornpan', query time: 0.03s
Refine Results
-
1
-
2
-
3
Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants by Chomchanat Tubjaroen, Sittichoke Prachuapthunyachart, Nattakoon Potjalongsilp, Pimpayao Sodsai, Nattiya Hirankarn, Peera Jaru-Ampornpan, Voranush Chongsrisawat
Published 2022-11-01
Article -
4
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial by Napaporn Chantasrisawad, Chonnamet Techasaensiri, Pope Kosalaraksa, Wanatpreeya Phongsamart, Auchara Tangsathapornpong, Peera Jaru-Ampornpan, Jiratchaya Sophonphan, Piyarat Suntarattiwong, Thanyawee Puthanakit
Published 2023-05-01
Article -
5
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents by Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Jiratchaya Sophonphan, Thutsanun Meepuksom, Thidarat Jupimai, Pimpayao Sodsai, Suvaporn Anugulruengkitt, Nattiya Hirankarn
Published 2022-12-01
Article -
6
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster by Napaporn Chantasrisawad, Thanyawee Puthanakit, Katesiree Kornsitthikul, Peera Jaru-Ampornpan, Monta Tawan, Pariya Matapituk, Jiratchaya Sophonphan, Suvaporn Anugulruengkitt, Auchara Tangsathapornpong, Apirat Katanyutanon
Published 2022-12-01
Article -
7
A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222 by Rapisa Nantanee, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Jitthiwa Athipunjapong, Jiratchaya Sophonphan, Sira Nanthapisal, Nattiya Hirankarn, Thanyawee Puthanakit
Published 2022-06-01
Article -
8
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance by Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Orawan Himananto, Supawan Papakhee, Jiratchaya Sophonphan, Monta Tawan, Thidarat Jupimai, Suvaporn Anugulruengkitt, Thanyawee Puthanakit
Published 2023-12-01
Article -
9
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine by Auchara Tangsathapornpong, Sira Nanthapisal, Kanassanan Pontan, Pornumpa Bunjoungmanee, Yamonbhorn Neamkul, Arthit Boonyarangkul, Supattra Wanpen, Waraphon Fukpho, Sumana Jitpokasem, Phuntila Tharabenjasin, Peera Jaru-Ampornpan
Published 2023-02-01
Article